Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

News & Events

Centre's research in the spotlight

The Children’s Diabetes Centre showcased its progress in paediatric Type 1 Diabetes research at a JDRF Australia event held at The Kids Research Institute Australia recently.

News & Events

Ads clinic update

The Perth Children’s Hospital (PCH) Adolescent Diabetes Service (ADS) clinics have had several updates thanks to your feedback, including the introduction of “Welcome to Ads group sessions” for teenagers.

News & Events

Research finds pumps deliver better long-term blood glucose control

New research from the Children’s Diabetes Centre at The Kids Research Institute Australia has found children who use an insulin pump to manage their type 1 diabetes have better long-term blood glucose control than those on insulin injections.

Research

'If I Wanted to Have More Opportunities and Go to a Better School, I Just Had to Get Used to It’

The experiences of 32 male Aboriginal students from regional and remote towns and communities while they attended a metropolitan boarding school...

News & Events

Dr Shaun Teo and Dr Paul Fournier awarded Diabetes Australia grants

A big congratulations to our The Kids and UWA researchers Dr Shaun Teo and Dr Paul Fournier who have both been awarded $70,000 grants for their diabetes research projects, under the 2023 Diabetes Australia Research Program (DARP).

News & Events

The PERSIST Study

The Persist Study Community Workshop. Help us to understand how to engage other youth who live with T1D!

News & Events

New Study: Water Survey UWA

There is evidence that physical activity is well known to increase the risk of hypoglycaemia in people with type 1 diabetes. However, little is known about the effect of water-based activities on blood glucose levels.

News & Events

New study: Diabetes stress and coping strategies

The Children’s Diabetes Centre is investigating the ways young people, and their primary carers, cope with stressors associated with type 1 diabetes.

Research

A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)

Pneumococcal disease (PD) remains a major health concern globally. In children, pneumococcal conjugate vaccines (PCVs) provide protection against PD from most vaccine serotypes, but non-vaccine serotypes contribute to residual disease. V114 is a 15-valent PCV containing all 13 serotypes in Prevnar 13™ and public health important serotypes 22F and 33F. This phase 3 study evaluated safety and immunogenicity of mixed PCV13/V114 regimens using a 3 + 1 dosing schedule when changing from PCV13 to V114 at doses 2, 3, or 4.